AG轮盘鸿博彩票 合法_从未抽烟也可能罹患慢阻肺:临床特征的鸠合综述 | 孟爱宏点评

皇冠账号

你的位置:皇冠账号 > 皇冠新网址 > AG轮盘鸿博彩票 合法_从未抽烟也可能罹患慢阻肺:临床特征的鸠合综述 | 孟爱宏点评
AG轮盘鸿博彩票 合法_从未抽烟也可能罹患慢阻肺:临床特征的鸠合综述 | 孟爱宏点评
发布日期:2024-05-12 01:17    点击次数:185

AG轮盘鸿博彩票 合法_从未抽烟也可能罹患慢阻肺:临床特征的鸠合综述 | 孟爱宏点评

AG轮盘鸿博彩票 合法_

  重要词:慢性胁制性肺疾病;从不抽烟者;系统综述;东说念主口特征

  一、

皇冠体育

  本系统综述的先容

  面前,慢性胁制性肺疾病(COPD)已成为寰球第三大死因。在COPD的诱因中,诚然抽烟是一个重要的环境危急身分,但现在依然意志到,寰宇上约30%的COPD病例发生在从不抽烟者 (NS) 中。然则,对于NS-COPD(从不抽烟者中的COPD)的流行病学、当然病史和临床特征尚不清亮。事实上,现在着实莫得任何成心针对NS-COPD患者的掂量。

  现存信息来自于对大型抽烟关系COPD部队中NS-COPD患者亚组的分析。基于这些脱落的不雅察,总结以为NS-COPD多发于年青女性,呼吸系统症状较轻,呼吸主义一样,但小器说念梗阻较严重,肺气肿较少,肺功能随时刻的下跌率较低,合并症发生率较低。从生物学角度看,NS-COPD患者痰中中性粒细胞减少,嗜酸性粒细胞增多,巨噬细胞归拢功能特殊。

  为进一步意志NS-COPD,在这里,咱们对关系文件进行了系统回想。

  二、

  检索战略、纳排程序和质地评估

  在PubMed (Medline) 和Embase数据库中进行文件检索,使用了以下开脱文本的不同组合;MeSH术语和布尔运算符: chronic obstructive pulmonary disease; chronic airflowobstruction; chronic airflow limitation; AND non-smokers OR never-smokers。检索时刻设定在2000年1月1日至2022年12月31日。

  纳入程序: (a) 稳妥条目的掂量预备包括部队掂量、病例对照掂量和横断面掂量; (b) 掂量东说念主群年级必须在18岁或以上,包括男性和女性,最小样本量为100名参与者,其中至少有20名患有COPD且从不抽烟; (c) 抹杀未提供从不抽烟者成果分类的掂量; (d) COPD的会诊必须基于临床症状和支气管推广剂后FEV1/FVC <0.70的客不雅肺活量测定阐述。完成进一步筛查,剔除不稳妥要求的文件后最终获取17篇论文,推论经过如图1所示。

皇冠客服飞机:@seo3687

  收受以下程序进行评估:样本量;NS-COPD病例数;掂量预备; COPD的会诊,每个边幅的得分从0到2,其中0为最低得分,8为总体最高得分 (如表1)。

  图1 本掂量纳入论文的采选经过 (PubMed, Embase, 2000-2022)

现在越来越开始关注体育比赛,博彩行业提供机会。

  表1 对所纳入边幅进行的质地评定

  COPD:慢性胁制性肺疾病;NS-COPD:从不抽烟者中的COPD;FEV1:第一秒使劲呼气容积;FVC:使劲肺活量;PBD:诈欺支气管推广剂后

  三、

皇冠体育注册送彩金88元

  成果及分析

  纳入的17项稳妥上述纳入/抹杀程序的掂量中:掂量的质地从2分(最小值)到6分(最大值),平均值为3.4分,标明合座质地为中-低质地。从患病率、严重进程、性别、年级、症状等方面进行议论分析,不错发现不同掂量间存在的彰着异质性。

  从症状上讲,NS-COPD患者大王人透露为轻度至中度气流受限,对应于GOLD品级1级和2级;纳入掂量中NS-COPD的性别关系缚论异质性很强,有7项掂量偏向于女性发病率大于男性,有5项掂量以为男性发病率是女性的3倍以上;8项掂量以为NS-COPD倾向于年级较大,中重度NS-COPD患病率跟着年级的增长而权贵加多,然则,在其他掂量中,未不雅察到NS-COPD和S-COPD受试者之间存在彰着的年级关系互异;此外,一些掂量一致以为,与S-COPD组比拟,NS-COPD组呼吸说念症状(慢性咳嗽、咳痰、呼吸穷苦和喘气)的患病率较低,比拟之下三份掂量阐发了更多的症状 (使劲时呼吸穷苦、慢性分娩性咳嗽和喘气)、更大的膂力步履界限、更差的疾病限度、更低的氧满盈度和更高的就诊次数。

  四、

  结  语

  这是第一个分析NS-COPD会诊尽头进展的临床特征的系统综述。本综述使用了成心为分内析预备的质地量表,然则,必须承认仍然存在一些潜在的界限,NS-COPD患者的样本量频繁较小,频繁来自于较大的COPD患者部队的一部分,并莫得凭据掂量的质地成心预备的病例对照掂量来笃定抽烟者与不抽烟者的病因或特征,也阑珊旨在不雅察COPD抽烟者与不抽烟者在其他临床成果方面是否存在互异的随访掂量。

  笔者团队掂量数据浮现(中国全科医学,已秉承,待发表),掂量纳入NS-COPD患者中,女性42例,占80.8%(样本量较小,可扩大样本量后进一步掂量),60岁以上NS-COPD患者47例,占89.4%,S-COPD与NS-COPD患者氧满盈度并莫得权贵互异(P=0.565);国际掂量中NS-COPD在不同性别漫步掂量成果互异较大,国际掂量与笔者数据均浮现NS-COPD中支气管炎型COPD多于肺气肿型COPD。

ag娱乐是哪个公司的a17aaa

  而现在咱们对于NS-COPD的常识严重阑珊,本系统综述中纳入的不同掂量具有高度的异质性,首要需要预备精采的掂量来访问其临床特征和疾病当然史,何况鉴于很多发达国度抽烟率下跌的趋势,这少许尤其首要。

鸿博彩票 合法

  参考文件

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD), in: Global Strategy for the Diagnosis, Management and Prevention of COPD; 2023 Report, GOLD: Fontana, WI, USA, 2023. Available online: https://goldcopd.org/2023-gold-report s-2/. (Accessed 8 January 2023).

  2. D. Adeloye, S. Chua, C. Lee, et al., Global and regional estimates of COPD prevalence: systematic review and meta-analysis, J. Glob. Health. 5 (2) (2015 Dec), 020415, https://doi.org/10.7189/jogh.05.020415. PMID: 26755942; PMCID: PMC4693508.

  3. G. Ntritsos, J. Franek, L. Belbasis, et al., Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis, Int. J. Chronic Obstr. Pulm. Dis. 13 (2018 May 10) 1507–1514, https://doi.org/10.2147/COPD.S146390. PMID: 29785100; PMCID: PMC5953270.

  4. M. Varmaghani, M. Dehghani, E. Heidari, F. Sharifi, S.S. Moghaddam, F. Farzadfar, Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis, East. Mediterr. Health J. 25 (1) (2019 Mar 19) 47–57, https://doi. org/10.26719/emhj.18.014.PMID:30919925.

  5. I.A. Yang, C.R. Jenkins, S.S. Salvi, Chronic obstructive pulmonary disease in neversmokers: risk factors, pathogenesis, and implications for prevention and treatment, Lancet Respir. Med. 10 (5) (2022 May) 497–511, https://doi.org/10.1016/S2213- 2600(21)00506-3. Epub 2022 Apr 12. PMID: 35427530.

  6. W.C. Tan, D.D. Sin, J. Bourbeau, et al., Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study, Thorax 70 (2015) 822–829.

  7. A. Agustí, J.C. Hogg, Update on the pathogenesis of chronic obstructive pulmonary disease, N. Engl. J. Med. 381 (13) (2019 Sep 26) 1248–1256, https://doi.org/ 10.1056/NEJMra1900475. PMID: 31553836.

  8. B. Lamprecht, M.A. McBurnie, W.M. Vollmer, et al., COPD in never smokers: results from the population-based burden of obstructive lung disease study, Chest 139 (4) (2011 Apr) 752–763, https://doi.org/10.1378/chest.10-1253. Epub 2010 Sep 30. PMID: 20884729; PMCID: PMC3168866.

AG轮盘

  9. G. Wang, A. Ma, L. Zhang, et al., Acute exacerbations of chronic obstructive pulmonary disease in a cohort of Chinese never smokers goes along with decreased risks of recurrent acute exacerbation, emphysema and comorbidity of lung cancer as well as decreased levels of circulating eosinophils and basophils, Front. Med. 9 (2022 Aug 10), 907893, https://doi.org/10.3389/fmed.2022.907893. PMID: 36035428; PMCID: PMC9400015.

C盘D盘是什么盘

  10. J.Y. Choi, J.W. Kim, Y.H. Kim, et al., Clinical characteristics of non-smoking chronic obstructive pulmonary disease patients: findings from the KOCOSS cohort, COPD 19 (1) (2022) 174–181, https://doi.org/10.1080/15412555.2022.2053088. PMID:35392750.

  11. S.S. Salvi, B.B. Brashier, J. Londhe, et al., Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease, Respir. Res. 21 (1) (2020 Feb 12) 50, https://doi.org/10.1186/s12931-020-1310-9. PMID: 32050955; PMCID: PMC7017521.

  12. F. Güldaval, G. Polat, S. Doruk, et al., What are the differences between smoker and non-smoker COPD cases? Is it a different phenotype? Turk. Thorac. J. 22 (4) (2021 Jul) 284–288, https://doi.org/10.5152/TurkThoracJ.2021.20147. PMID: 35110244; PMCID: PMC8975314.

  13. A. Ramírez-Venegas, F. Montiel-Lopez, R. Falfan-Valencia, G. P´erez-Rubio, R. H. Sansores, The “slow horse racing effect” on lung function in adult life in chronic obstructive pulmonary disease associated to biomass exposure, Front. Med. 8 (2021 Jul 8), 700836, https://doi.org/10.3389/fmed.2021.700836. PMID: 34307427; PMCID: PMC8295605.

  14. J. Bajpai, S. Kant, D.K. Bajaj, A. Pradhan, K. Srivastava, A.K. Pandey, Clinical, demographic and radiological profile of smoker COPD versus nonsmoker COPD patients at a tertiary care center in North India, J. Fam. Med. Prim. Care 8 (7) (2019 Jul) 2364–2368, https://doi.org/10.4103/jfmpc.jfmpc_347_19. PMID: 31463258; PMCID: PMC6691458.

  15. J. Zhang, X. Lin, C. Bai, S. Bai, Comparison of clinical features between nonsmokers with COPD and smokers with COPD: a retrospective observational study, Int. J. Chronic Obstr. Pulm. Dis. 9 (1) (2014) 57–63, https://doi.org/10.2147/ COPD.S52416.

  16. Sexton Paul, Peter Black, Lian Wu, et al., Chronic obstructive pulmonary disease in non-smokers: a case-comparison study, COPD, J. Chronic Obstr. Pulm. Dis. 11 (1) (2014) 2–9, https://doi.org/10.3109/15412555.2013.800853.

  17. D.M. Shah, R.M. Kshatriya, R. Paliwal, Comparison of demographic, clinical,皇冠账号 spirometry, and radiological parameters between smoking and non-smoking COPD patients in rural Gujarat, India, J. Fam. Med. Prim. Care 10 (2021) 3343–3347.

  18. E. Fuller-Thomson, R.S. Chisholm, S. Brennenstuhl, COPD in a population-based sample of never-smokers: interactions among sex, gender, and race, Int. J. Chronic. Dis. 2016 (2016), 5862026, https://doi.org/10.1155/2016/5862026. Epub 2016 Dec 7. PMID: 28054032; PMCID: PMC5174166.

  19. S.H. Lee, E.D. Hwang, J.E. Lim, et al., The risk factors and characteristics of COPD among nonsmokers in korea: an analysis of KNHANES IV and V, Lung 194 (3) (2016 Jun) 353–361, https://doi.org/10.1007/s00408-016-9871-6. Epub 2016 Apr 1. PMID: 27038474.

  20. P.O. Bridevaux, N.M. Probst-Hensch, C. Schindler, et al., Prevalence of airflow obstruction in smokers and never-smokers in Switzerland, Eur. Respir. J. 36 (6) (2010) 1259–1269, https://doi.org/10.1183/09031936.00004110.

  21. M. Thomsen, B.G. Nordestgaard, J. Vestbo, P. Lange, Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study, Lancet Respir. Med. 1 (7) (2013 Sep) 543–550, https://doi.org/10.1016/S2213-2600(13)70137-1. Epub 2013 Jul 29. PMID: 24461615.

  22. M.J. Page, J.E. McKenzie, P.M. Bossuyt, et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ (2021 Mar 29) 372, https://doi.org/10.1136/bmj.n71, n71.

  23. M. P´erez-Ríos, A. Schiaffino, M.J. Lopez, ´ et al., Questionnaire-based second-hand smoke assessment in adults, Eur. J. Publ. Health 23 (5) (2013 Oct) 763–767, https://doi.org/10.1093/eurpub/cks069. Epub 2012 Jun 8. PMID: 22683770.

  24. M. Torres-Dur´ an, J.M. Barros-Dios, A. Fern´ andez-Villar, A. Ruano-Ravina, Residential radon and lung cancer in never smokers. A systematic review, Cancer Lett. 345 (1) (2014 Apr 1) 21–26, https://doi.org/10.1016/j.canlet.2013.12.010. Epub 2013 Dec 11. PMID: 24333737.

  25. Rodríguez-Martínez A, ´ M. Torres-Duran, ´ J.M. Barros-Dios, A. Ruano-Ravina, Residential radon and small cell lung cancer. A systematic review, Cancer Lett. 426 (2018 Jul 10) 57–62, https://doi.org/10.1016/j.canlet.2018.04.003. Epub 2018 Apr 11. PMID: 2965489.

皇冠信用怎么开账户

  26. S. Hagstad, L. Ekerljung, A. Lindberg, H. Backman, E. Ronmark, ¨ B. Lundback, ¨ COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies, Respir. Med. 106 (7) (2012 Jul) 980–988, https://doi.org/ 10.1016/j.rmed.2012.03.010. Epub 2012 Apr 11. PMID: 22498109.

  27. M. Denguezli, H. Daldoul, I. Harrabi, et al., COPD in nonsmokers: reports from the Tunisian population-based burden of obstructive lung disease study, PLoS One 11 (3) (2016 Mar 24), e0151981, https://doi.org/10.1371/journal.pone.0151981. PMID: 27010214; PMCID: PMC4807055.

  28. T. Soumagne, A. Guillien, N. Roche, J.C. Dalphin, B. Degano, Never-smokers with occupational COPD have better exercise capacities and ventilatory efficiency than matched smokers with COPD, 2020 Dec 1, J. Appl. Physiol. 129 (6) (1985) 1257–1266, https://doi.org/10.1152/japplphysiol.00306.2020. Epub 2020 Oct 1. PMID: 33002379.

  29. S. Hagstad, H. Backman, A. Bjerg, et al., Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - occupational exposure to gas, dust or fumes is an important risk factor, Respir. Med. 109 (11) (2015 Nov) 1439–1445, https://doi.org/10.1016/j.rmed.2015.09.012. Epub 2015 Sep 26. PMID: 26440676.

美女荷官

  30. M. Miravitlles, M. Ferrer, A. Pont, J. Luis Viejo, et al., Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers, Respir. Med. 99 (8) (2005 Aug) 985–995, https://doi.org/10.1016/j.rmed.2005.01.012. Epub 2005 Mar 4. PMID: 15950139.

  31. B. Lamprecht, L. Schirnhofer, B. Kaiser, S. Buist, M. Studnicka, Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study, Respir. Med. 102 (12) (2008 Dec) 1833–1838, https://doi.org/10.1016/j. rmed.2008.07.007. Epub 2008 Aug 22. PMID: 18722100.

  32. B. Cushen, I. Sulaiman, N. Donoghue, et al., High prevalence of obstructive lung disease in non-smoking farmers: the Irish farmers lung health study, Respir. Med. 115 (2016 Jun) 13–19, https://doi.org/10.1016/j.rmed.2016.04.006. Epub 2016 Apr 20. PMID: 27215498.

  33. Y. Zhou, C. Wang, W. Yao, et al., COPD in Chinese nonsmokers, Eur. Respir. J. 33 (3) (2009 Mar) 509–518, https://doi.org/10.1183/09031936.00084408.PMID: 19251797.

  34. H. Lee, Y. Hong, M.N. Lim, et al., Inflammatory biomarkers and radiologic measurements in never-smokers with COPD: a cross-sectional study from the CODA cohort, Chron. Respir. Dis. 15 (2) (2018 May) 138–145, https://doi.org/10.1177/ 1479972317736293.Epub2017Nov8. PMID: 29117798; PMCID: PMC5958470.

  35. J. Montserrat-Capdevila, P. Godoy, J.R. Marsal, et al., Prevalencia y características de la enfermedad pulmonar obstructiva cronica ´ en no fumadores [Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers], Spanish, Atencion ´ Primaria 51 (10) (2019 Dec) 602–609, https://doi.org/10.1016/j. aprim.2017.10.012. Epub 2018 Nov 16. PMID: 30454958; PMCID: PMC6930941.

  36. N. Nguyen Viet, F. Yunus, A. Nguyen Thi Phuong, et al., The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: an observational survey, Respirology 20 (4) (2015 May) 602–611, https://doi.org/10.1111/resp.12507. Epub 2015 Mar 17. PMID: 25781616.

  37. P.G. Camp, A. Ramirez-Venegas, R.H. Sansores, et al., COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women, Eur. Respir. J. 43 (3) (2014 Mar) 725–734, https://doi.org/10.1183/09031936.00206112. Epub 2013 Oct 10. PMID: 24114962.

  38. R. Perez-Padilla, R. Fernandez, M.V. Lopez Varela, et al., Airflow obstruction in never smokers in five Latin American cities: the PLATINO study, Arch. Med. Res. 43 (2) (2012 Feb) 159–165, https://doi.org/10.1016/j.arcmed.2012.03.007. Epub 2012 Apr 2. PMID: 22475778.

  39. O.B. Ojuawo, A.O. Aladesanmi, C.M. Opeyemi, et al., Profile of patients with chronic obstructive pulmonary disease in Ilorin who were never-smokers, Niger. J. Clin. Pract. 22 (2) (2019 Feb) 221–226, https://doi.org/10.4103/njcp.njcp_344_ 18.PMID:30729946.

  40. A. Agustí, G. Noell, J. Brugada, R. Faner, Lung function in early adulthood and health in later life: a transgenerational cohort analysis, Lancet Respir. Med. 5 (2017) 935–945.

  41. S. Stanojevic, D.A. Kaminsky, M.R. Miller, et al., ERS/ATS technical standard on interpretive strategies for routine lung function tests, Eur. Respir. J. 60 (1) (2022 Jul 13), 2101499, https://doi.org/10.1183/13993003.01499-2021.PMID: 34949706.

  42. Salvi SS, Brashier BB, Londhe J, et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020;21(1):50. Published 2020 Feb 12. doi:10.1186/s12931-020-1310-9

  43. Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco Product Use Among Adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736-1742. Published 2020 Nov 20. doi:10.15585/mmwr.mm6946a4

  44. World Health Organization. Regional Office for Europe. (2019). European tobacco use: trends report 2019. World Health Organization. Regional Office for Europe. https://apps.who.int//iris/handle/10665/346817

  本 期 作 者

  孟爱宏 主任大夫

  医学博士/主任大夫/磨真金不怕火/博士生导师

  河北医科大学第二病院北院区呼吸与危重症医学科主任

  张智伟 硕士掂量生

此外,太阳能(000591)级多晶硅产量环比下降3.3%,同比增长27.2%;组件产量环比下降3.9%,同比增长44.9%,其中单晶组件产量占比约99.8%;逆变器产量环比下降10.7%,同比增长34.2%。

  河北医科大学第二病院

  本文仅代表作家个东说念主不雅点

iba娱乐

  仅供医务东说念主员参考

  接待投稿至:conwhite_8@hotmail.com 6868体育